Name | 5-bromo-2-[2-(4-chlorophenyl)oxiran-2-yl]pyridine |
---|---|
Synonyms |
Pyridine,5-bromo-2-[2-(4-chlorophenyl)-2-oxiranyl]
2-(4-chloro-phenyl)-2-(5-bromo-pyridin-2-yl)-oxirane |
Molecular Formula | C13H9BrClNO |
---|---|
Molecular Weight | 310.57400 |
Exact Mass | 308.95600 |
PSA | 25.42000 |
LogP | 3.77130 |
~81% 917899-54-8 |
Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 209 ; WO 2006/136830 A1 |